通心络；低分子肝素钙；不稳定型心绞痛。
Tongxinluo; low molecular heparin; unstable angina pectoris.
目的：观察低分子肝素钙治疗脑梗死的有效性和安全性。
Objective: To explore the safety and efficiency of low molecular heparin calcium treating cerebral infarction.
目的：观察小剂量低分子肝素钙治疗糖尿病肾病的疗效。
Objective: To observe the curative effect of small dose low molecular heparin calcic in the treatment of diabetic nephropathy.
结论：低分子肝素钙治疗2型糖尿病肾病是安全有效的。
Conclusion: low molecular weight heparin calcic is safer and more effective than the control group in the treatment of type 2 diabetic nephropathy.
目的：观察低分子肝素钙对2型糖尿病肾病的疗效和安全性。
Objective: To observe the safety and efficacy of low molecular weight heparin calcic in treatment of type2 diabetic nephropathy.
目的探讨小剂量尿激酶与低分子肝素钙治疗急性脑梗死的疗效。
Objective To discuss the curative effect of the small dosage urokinase and the low molecular heparin calcium on cerebral infarction.
目的观察低分子肝素钙在预防小儿过敏性紫癜肾损害中的作用。
Objective To evaluate the therapeutical effect of low molecular heparin calcium in the prevention of Henoch-Schonlein purpura nephritis (HSPN).
目的评价低分子肝素钙治疗不稳定型心绞痛(uap)的效果。
Objective to determine the therapeutic effectiveness of low molecular weight heparin calcium in treating unstable angina pectoris (UAP).
目的探讨低分子肝素钙治疗过敏性紫癜及预防紫癜性肾炎的作用。
Objective To evaluate the effectivity of low molecular heparin calcium in treating Henoch-Schonlein purpura and preventing Henoch-Schonlein purpura nephritis(HSPN).
结果：丁咯地尔组疗效较好，奥扎格雷组和低分子肝素钙组次之。
Result: The effect of buflomedil group was better than ozagrel group and low molecular heparin calcium group.
目的观察低分子肝素钙联合东菱克栓酶治疗进展性脑梗死的疗效。
Objective To observe the therapeutic efficacy of combination of low-molecular weight heparin and Batroxobin(DF-521)on progressive stroke.
目的观察低分子肝素钙联合冠心宁治疗不稳定型心绞痛的临床疗效。
Objective To observe the curative effect on treatment of unstable angina with low molecular heparin calcium (LMHC) combined with Guanxinnin injection.
前言：目的：探讨三种低分子肝素钙治疗不稳定性心绞痛的经济效果。
Objective: To investigate the economics consequences of low molecular heparin in the treatment of UAP.
目的观察血栓通注射液联合低分子肝素钙治疗不稳定型心绞痛的临床疗效。
Objective To study the clinical effects of Xueshuantong with low molecular weight heparin for unstable angina(UA).
结论尤瑞克林联合低分子肝素钙治疗可作为治疗进展性脑卒中的方法之一。
Conclusion Yuri orlov klingenberg low molecular heparin calcium combined treatment can be used as the recent advances in the treatment of cerebral apoplexy one way.
目的观察低分子肝素钙、阿司匹林及其联合应用治疗急性脑梗死的疗效及其安全性。
OBJECTIVE To study the efficacy and safety of low-molecular-weight heparin calcium and aspirin on treating acute cerebral infarction.
目的：评价低分子肝素钙联合大剂量纳洛酮治疗早期急性脑梗死的临床疗效和安全性。
AIM: To evaluate the therapeutic effect and safety of low molecular weight heparin calcium combined with naloxone on acute cerebral infraction in early stage.
结论脑梗死急性期给予低分子肝素钙联合阿司匹林治疗安全有效，且明显优于单药治疗。
CONCLUSION The earlier treatment of acute cerebral infarction with low-molecular-weight heparin calcium and aspirin is safe and effective.
目的：探讨低分子肝素钙治疗因抗磷脂抗体所致复发性流产的疗效及对孕妇血液中抗体的影响。
AIM: To explore the effect of low-molecular weight heparin calcium in treating recurrent abortion induced by anti-phospholipid antibody and the influence of the antibodies in gravida blood.
因此，血液灌流抢救急性药物中毒的抗凝方法中低分子肝素钙明显优于无肝素法和普通肝素法。
We conclude that low molecular heparinate is superior to the other methods for anticoagulation in emergence treatment of acute p…
结论使用肠溶阿司匹林和低分子肝素钙联合治疗急性脑梗塞疗效好，使用简便、安全、经济，可在临床予推广应用。
Conclusion it is quite effective, convenient, safe, economical and commendatory to use aspirin and low molecular weight heparin in acute cerebral infarction therapy.
那屈肝素钙在ACS治疗上是否比其他低分子量肝素有优势？
Does Nadroparin Calcium have any advantage in ACS treatment over other LMWHs?
结论：本文建立的低分子量肝素钙注射液细菌内毒素检查法可行。
CONCLUSION:It is feasible to detect bacterial endotoxins in LMWHC by TAL test.
结论：本文建立的低分子量肝素钙注射液细菌内毒素检查法可行。
CONCLUSION:It is feasible to detect bacterial endotoxins in LMWHC by TAL test.
应用推荐